Herbalife（HOO）株式概要ハーバライフ・リミテッドはその子会社とともに、北米、メキシコ、中南米、ヨーロッパ、中東、アフリカ、中国、アジア太平洋地域で健康とウェルネス製品を提供している。 詳細HOO ファンダメンタル分析スノーフレーク・スコア評価5/6将来の成長2/6過去の実績1/6財務の健全性1/6配当金0/6報酬当社が推定した公正価値より83.6%で取引されている 収益は年間15.81%増加すると予測されています 同業他社や業界と比較して、良好な取引価格 リスク分析利払いは収益で十分にカバーされない マイナスの株主資本 過去3か月間に大規模なインサイダー売却が発生 すべてのリスクチェックを見るHOO Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€10.3230.6% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture06b2016201920222025202620282031Revenue US$6.0bEarnings US$280.1mAdvancedSet Fair ValueView all narrativesHerbalife Ltd. 競合他社BeiersdorfSymbol: XTRA:BEIMarket cap: €16.0bRunben BiotechnologySymbol: SHSE:603193Market cap: CN¥9.0bAMOREPACIFIC HoldingsSymbol: KOSE:A002790Market cap: ₩1.9tSYoung GroupSymbol: SZSE:300740Market cap: CN¥9.8b価格と性能株価の高値、安値、推移の概要Herbalife過去の株価現在の株価US$10.3252週高値US$16.8152週安値US$6.46ベータ0.991ヶ月の変化-26.39%3ヶ月変化-35.98%1年変化54.40%3年間の変化-6.18%5年間の変化-76.52%IPOからの変化85.78%最新ニュースRecent Insider Transactions • May 25Chief Operating Officer recently sold €452k worth of stockOn the 19th of May, Troy Hicks sold around 41k shares on-market at roughly €11.12 per share. This transaction amounted to 91% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €1.6m. This was Troy's only on-market trade for the last 12 months.Recent Insider Transactions • May 20Chief Commercial Officer recently sold €1.6m worth of stockOn the 12th of May, Frank Lamberti sold around 143k shares on-market at roughly €11.53 per share. This transaction amounted to 80% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €1.5m more than they bought in the last 12 months.お知らせ • Apr 01Herbalife Ltd. to Report Q1, 2026 Results on May 06, 2026Herbalife Ltd. announced that they will report Q1, 2026 results After-Market on May 06, 2026お知らせ • Mar 18Herbalife Ltd., Annual General Meeting, Apr 30, 2026Herbalife Ltd., Annual General Meeting, Apr 30, 2026. Location: 800 w. olympic blvd, suite 406, los angeles, ca 90015, United Statesお知らせ • Feb 19+ 1 more updateHerbalife Ltd. Provides Earnings Guidance for the First Quarter and Full Year 2026Herbalife Ltd. provided earnings guidance for the first quarter and full year 2026. For the quarter, The company expects reported net sales from +3.0% to +7.0% year-over-year. For the year, The company expects reported net sales from +1.0% to +6.0% year-over-year.お知らせ • Jan 05Herbalife Ltd. to Report Q4, 2025 Results on Feb 18, 2026Herbalife Ltd. announced that they will report Q4, 2025 results After-Market on Feb 18, 2026最新情報をもっと見るRecent updatesRecent Insider Transactions • May 25Chief Operating Officer recently sold €452k worth of stockOn the 19th of May, Troy Hicks sold around 41k shares on-market at roughly €11.12 per share. This transaction amounted to 91% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €1.6m. This was Troy's only on-market trade for the last 12 months.Recent Insider Transactions • May 20Chief Commercial Officer recently sold €1.6m worth of stockOn the 12th of May, Frank Lamberti sold around 143k shares on-market at roughly €11.53 per share. This transaction amounted to 80% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €1.5m more than they bought in the last 12 months.お知らせ • Apr 01Herbalife Ltd. to Report Q1, 2026 Results on May 06, 2026Herbalife Ltd. announced that they will report Q1, 2026 results After-Market on May 06, 2026お知らせ • Mar 18Herbalife Ltd., Annual General Meeting, Apr 30, 2026Herbalife Ltd., Annual General Meeting, Apr 30, 2026. Location: 800 w. olympic blvd, suite 406, los angeles, ca 90015, United Statesお知らせ • Feb 19+ 1 more updateHerbalife Ltd. Provides Earnings Guidance for the First Quarter and Full Year 2026Herbalife Ltd. provided earnings guidance for the first quarter and full year 2026. For the quarter, The company expects reported net sales from +3.0% to +7.0% year-over-year. For the year, The company expects reported net sales from +1.0% to +6.0% year-over-year.お知らせ • Jan 05Herbalife Ltd. to Report Q4, 2025 Results on Feb 18, 2026Herbalife Ltd. announced that they will report Q4, 2025 results After-Market on Feb 18, 2026お知らせ • Nov 13Herbalife Expands Liftoff Energy Line with New Cola and Ginger Beer FlavorsHerbalife announced the expansion of its Liftoff energy product line with two new flavors: Cola and Ginger Beer. The zero-sugar, low-calorie mental-focus and energy-boosting supplement combines the effervescent taste of classic soda with science-backed ingredients. Available exclusively through Herbalife's Independent Distributors, the new flavors come in convenient stick packs for active, on-the-go consumers and are available exclusively in the United States and Puerto Rico. Herbalife expands its Liftoff energy line with two new soda-inspired flavors, Cola and Ginger Beer, available in convenient stick packs through Herbalife Independent Distributors in the United States and Puerto Puerto Rico. The U.S. energy drink market is projected to grow to $41.4 billion by 2033 driven by rising demand for functional beverages1. Amid that growth and since its introduction in 2005, Liftoff stands out as a low-calorie option that combines popular flavors with science-backed nutrition. Each serving contains 75 mg of caffeine to feel energized and focused, Panax ginseng to support mental alertness+, vitamin C for antioxidant protection, and a full spectrum of B vitamins for energy metabolism support. Liftoff is ranked among Herbalife's top-selling products. Its popularity is driven by the company's large network of Independent Distributors and their customers who trust and enjoy the product because of its proven benefits. The success of Liftoff can be attributed to its heavy adoption in the community of Herbalife's network of over 10,000 nutrition clubs in the U.S. These independently owned health and wellness centers provide a space where consumers can connect with a community of like-minded people, health-focused products, and receive personalized support. At nutrition clubs, Liftoff is a popular selection that supports overall health and wellness goals. Herbalife also offers Herbalife24 Liftoff as part of its sports nutrition line, developed to meet the energy, hydration and recovery needs of athletes and active individuals. The Herbalife24 line is NSF Certified for Sport®?++, a third-party certification that confirms products meet the highest standards for quality, safety, and competitive use, giving professional athletes confidence in their performance nutrition choices. Liftoff is available in more than 65 markets worldwide and continues to be a core part of Herbalife's functional energy portfolio. Earlier this year, Liftoff launched in India with a new Watermelon flavor, marking the brand's first entry into that region. Globally, the Liftoff line features more than 10 flavors, reflecting Herbalife's commitment to delivering functional, science-backed energy solutions tailored to local consumer preferences.お知らせ • Nov 06+ 1 more updateHerbalife Ltd. Revises Earnings Guidance for the Full-Year 2025Herbalife Ltd. revised earnings guidance for the Full-Year 2025. For the period, Company now expects Net Sales in the range of (0.3)% to +0.7% YoY against previous guidance of (1.0)% to +3.0% YoY.お知らせ • Oct 01Herbalife Ltd. to Report Q3, 2025 Results on Nov 05, 2025Herbalife Ltd. announced that they will report Q3, 2025 results After-Market on Nov 05, 2025お知らせ • Aug 07+ 1 more updateHerbalife Ltd. Revises Earnings Guidance for Full Year of 2025Herbalife Ltd. revised earnings guidance for full year of 2025. For the period, the company now expects net sales of negative 1.0% to positive 2.5% year on year as compared to previous guidance of negative 2.5% to positive 2.5% Year on year.お知らせ • Jul 07Herbalife Ltd. Launches MultiBurn™?Herbalife Ltd. announced the launch of MultiBurn™? -- a next-generation multi-action dietary supplement designed with clinically studied botanical extracts to support key areas of metabolic health. Formulated by Herbalife's global team of scientists and nutrition experts, MultiBurn™? is gluten-free, suitable for vegans and made without synthetic colors or dyes, reflecting the company's commitment to clean-label, user-friendly wellness solutions. As consumers continue to seek weight loss solutions, Herbalife offers an innovative, non-pharmaceutical approach with MultiBurn™?, a product grounded in science-backed ingredients and a continued commitment to wellness innovation. Built on a foundation of clinical research, MultiBurn™? features a powerful blend of three botanical ingredients: Morosil™? (from Moro blood oranges): supports overall weight loss, including reduced hip and waist interference and a healthy BMI ++. Metabolaid®? (hibiscus and lemon Verbena extract): helps with healthy reduction of fat and increased feeling of fullness after meals ++. Capsifen™? (red chili pepper and fenugreek blend): supports healthy energy expenditure. MultiBurn™? also contains supporting functional ingredients, including caffeine to stimulate metabolism and provide a feeling of energy and alertness, and chromium to aid in maintaining blood sugar levels already within the normal range. It can also be integrated into a broader Herbalife routine, complementing products such as high-protein shakes, fiber supplements and targeted wellness solutions -- all supported by Herbalife's global community of Independent Distributors who provide personalized guidance to millions of customers to achieve their weight loss and wellness goals. For 45 years, Herbalife has been committed to personalized nutrition and science-backed wellness. The company's very first product, Formula 1 Healthy Meal Nutritional Shake Mix, revolutionized meal replacement nutrition and is the #1 protein shake in the world -- sold in over 90 countries and trusted by millions. Recognized as the #1 active and lifestyle nutrition brand in the world2, Herbalife offers an extensive portfolio of products designed to support healthy weight management, sports performance, daily nutrition and promote skin and body care to help individuals at every stage of their wellness journey. MultiBurn™? builds on this legacy as part of Herbalife's ongoing evolution, bringing together clinical research, ingredient transparency and innovative formulation to address the modern consumer demand for whole-person wellness. MultiBurn™? is now available in the United States, and will be launching in Puerto Rico in September 2025. For more information on MultiBurn™?, please click here. Herbalife products are available exclusively through Herbalife Independent Distributors. To purchase Herbalife's MultiBurn™? in the United States or Puerto Rico, consumers can call 1-888-443-7225. For specific questions about using Herbalife products with other weight-loss therapies, contact Herbalife's dedicated team of health and safety professionals at . These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.++ In combination with a healthy diet and active lifestyle.お知らせ • Jul 02Herbalife Ltd. to Report Q2, 2025 Results on Aug 06, 2025Herbalife Ltd. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025お知らせ • Jun 30+ 2 more updatesHerbalife Ltd.(NYSE:HLF) dropped from Russell 2000 Growth-Defensive IndexHerbalife Ltd.(NYSE:HLF) dropped from Russell 2000 Growth-Defensive Indexお知らせ • Jun 12Herbalife Ltd’s Aloin Identification Method for Aloe Vera Officially Recognized by AOAC INTERNATIONALHerbalife Ltd. announced the Association of Official Analytical Collaboration (AOAC INTERNATIONAL)—a global authority in analytical science—has formally certified its proprietary method for identifying and measuring anthraquinones, also known as aloins, in aloe vera. Aloe regulatory groups require producers of ingestible aloe vera products to monitor naturally occurring compounds such as aloin A, aloin B, and aloe-emodin to meet safety guidelines. This certification officially recognizes Herbalife’s longstanding method as the world’s first AOAC-approved approach for detecting aloins—reinforcing safety and quality benchmarks across botanical and dietary supplement industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250611798277/en/. Developed by Herbalife scientists and validated by independent laboratories worldwide, this AOAC-certified method is used to test every batch of Herbalife’s aloe-based products, ensuring safety, while preserving aloe vera’s natural benefits. Aloe vera is a key ingredient in many of Herbalife’s top products, which are sold in more than 90 markets. Herbalife’s method was validated through a global multi-laboratory study involving eight independent laboratories. Each lab tested the same set of six aloe vera samples, including both raw materials and finished products, using HPLC (High-Performance Liquid Chromatography) to measure aloin A, aloin B, and aloe-emodin. The study ensured the method's accuracy and reliability across various labs and product types, with results confirming that it met all performance criteria, including precision and system suitability. Herbalife has a long-standing commitment to aloe vera research and quality assurance. This dedication has resulted in five patents and three published studies focused on developing safe extraction methods that preserve the plant’s natural benefits. While many companies rely solely on supplier certifications to confirm the authenticity of their aloe vera, Herbalife goes further. The company is one of the few in the world using advanced proton nuclear magnetic resonance (NMR) spectrometry—an analytical technique that uses magnetic fields and radio waves to identify the molecular structure of raw materials. This allows Herbalife to independently verify the identity and purity of its aloe vera at the molecular level, ensuring the highest standards of quality, consistency and traceability across its global supply chain.お知らせ • May 01+ 2 more updatesHerbalife Ltd. (NYSE:HLF) completed the acquisition of The assets of Pro2col Health.Herbalife Ltd. (NYSE:HLF) signed a letter of intent to acquire The assets of Pro2col Health on March 12, 2025. In related transactions Herbalife Ltd. also entered into a binding memorandum of understanding to acquire 100% of the assets of Pruvit Ventures and to acquire 51% stake in Link BioSciences Inc. The transactions will cost approximately $25 million to $30 million, with additional conditional payments possible based on future performance. The expected completion of the transaction is in the second quarter of 2025. Herbalife Ltd. (NYSE:HLF) completed the acquisition of The assets of Pro2col Health in April, 2025.お知らせ • Apr 26Herbalife Ltd. Elects Lynda Cloud to Its Board of Directors, Effective April 23, 2025Herbalife Ltd. announced the election of Lynda Cloud to its Board of Directors, effective April 23, 2025. This appointment reflects Herbalife’s continued commitment to innovation, digital transformation, and personalized wellness. Lynda Cloud’s decades of leadership across education, technology, and health sectors make her uniquely equipped to support Herbalife’s next chapter. Her deep expertise in digital learning, consumer experience, and scalable education aligns with Herbalife’s strategic priorities to modernize, expand personalized wellness offerings, and build stronger, more connected communities across its global platform. Ms. Cloud brings nearly 30 years of leadership experience. Most recently, she served as CEO of the Institute for Integrative Nutrition (IIN), where she led a major global expansion of digital wellness education. Her previous leadership roles include CEO of Equal Ed and Executive Vice President at K12 Inc., where she spearheaded innovation in online learning and virtual school development.お知らせ • Apr 01Herbalife Ltd. to Report Q1, 2025 Results on Apr 30, 2025Herbalife Ltd. announced that they will report Q1, 2025 results After-Market on Apr 30, 2025お知らせ • Mar 13+ 2 more updatesHerbalife Ltd. (NYSE:HLF) entered into a binding memorandum of understanding to acquire the assets of Pruvit Ventures, Inc.Herbalife Ltd. (NYSE:HLF) entered into a binding memorandum of understanding acquire to the assets of Pruvit Ventures, Inc. on March 12, 2025. In related transactions Herbalife Ltd. also entered into a binding memorandum of understanding to acquire 100% of the assets of Pro2col Health LLC and to acquire 51% stake in Link BioSciences Inc. The transactions will cost approximately $25 million to $30 million, with additional conditional payments possible based on future performance. The expected completion of the transaction is in the second quarter of 2025.お知らせ • Feb 21Herbalife Ltd. Provides Earnings Guidance for the First Quarter and Full Year 2025Herbalife Ltd. provided earnings guidance for the first quarter and full year 2025. For the quarter, the company expected Net sales from negative 5.5% to negative 1.5% year-over-year. For the year, the company expected Net sales from negative 3% to positive 3% year-over-year.お知らせ • Feb 20+ 1 more updateHerbalife Ltd Announces Executive ChangesHerbalife Ltd. announced that Michael Johnson, current CEO and Chairman of the Board, will transition to Executive Chairman. As part of the planned leadership transition, Herbalife Managing Director of International Markets, Rob Levy, will take on the role of President, Worldwide Markets, also effective May 1, 2025. Mr. Levy has held several senior leadership roles and has led every region during his 30-year tenure with Herbalife. In his current role, Mr. Levy is responsible for all business, strategy, sales, and marketing functions across 43 markets internationally as well as international expansion. All Regional Managing Directors will report to Mr. Levy.お知らせ • Jan 03Herbalife Ltd. to Report Q4, 2024 Results on Feb 19, 2025Herbalife Ltd. announced that they will report Q4, 2024 results on Feb 19, 2025Valuation Update With 7 Day Price Move • Nov 06Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €7.31, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 20x in the Personal Products industry in Europe. Total loss to shareholders of 80% over the past three years.お知らせ • Nov 02+ 1 more updateHerbalife Ltd. Provides Earnings Guidance for the Fourth Quarter of 2024Herbalife Ltd. provided earnings guidance for the Fourth quarter of 2024. For the quarter, the company expects net sales to be between at negative 3.0% to positive 1.0% year-over-year.Reported Earnings • Nov 01Third quarter 2024 earnings released: EPS: US$0.47 (vs US$0.43 in 3Q 2023)Third quarter 2024 results: EPS: US$0.47 (up from US$0.43 in 3Q 2023). Revenue: US$1.24b (down 3.2% from 3Q 2023). Net income: US$47.4m (up 11% from 3Q 2023). Profit margin: 3.8% (up from 3.3% in 3Q 2023). Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 49% per year whereas the company’s share price has fallen by 44% per year.お知らせ • Oct 01Herbalife Ltd. to Report Q3, 2024 Results on Oct 30, 2024Herbalife Ltd. announced that they will report Q3, 2024 results After-Market on Oct 30, 2024Valuation Update With 7 Day Price Move • Sep 10Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to €6.15, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 23x in the Personal Products industry in Europe. Total loss to shareholders of 84% over the past three years.Valuation Update With 7 Day Price Move • Aug 07Investor sentiment deteriorates as stock falls 24%After last week's 24% share price decline to €8.60, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 21x in the Personal Products industry in Europe. Total loss to shareholders of 79% over the past three years.New Risk • Aug 01New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 29% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Negative equity (-US$1.0b). Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.6% net profit margin).Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: US$0.047 (vs US$0.60 in 2Q 2023)Second quarter 2024 results: EPS: US$0.047 (down from US$0.60 in 2Q 2023). Revenue: US$1.28b (down 2.5% from 2Q 2023). Net income: US$4.70m (down 92% from 2Q 2023). Profit margin: 0.4% (down from 4.6% in 2Q 2023). Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 35% per year, which means it has not declined as severely as earnings.お知らせ • Aug 01Herbalife Ltd. Provides Earnings Guidance for the Third Quarter of 2024 and Revised Earnings Guidance for the Full Year of 2024Herbalife Ltd. provided earnings guidance for the third quarter of 2024 and revised earnings guidance for the full year of 2024. For the quarter, the company expects net sales to be between (4.5)% to 0% year-over-year. For the full year, the company expects net sales to be between (3.5)% to 1.5% year-over-year against previous guidance of 0% to 5% year-over-year.お知らせ • Jul 23Herbalife Introduces Protein Chips, A New Nutritious Snack Option to Meet Increased Consumer Demand for Protein FoodsHerbalife introduced Protein Chips in the United States and Puerto Rico. Protein Chips are the Company's latest protein snack offering, providing consumers with a healthy, savory and convenient way to help meet their daily nutrition goals. With consumers seeking more convenient and savory ways to integrate protein into their diets, especially as snacking replaces conventional meals among younger demographics, protein foods have been gaining traction. Protein Chips are backed by science and rigorously tested for quality. They are available in mild barbeque flavor and come in convenient on-the-go packs. Protein Chips are Gluten-Free Certified, suitable for vegetarians, toasted, not fried and contain: 8 grams of plant-based pea protein; Natural flavor; No cholesterol. Protein Chips are available exclusively through Herbalife independent distributors. Click here to learn more about this product.Valuation Update With 7 Day Price Move • Jul 17Investor sentiment improves as stock rises 15%After last week's 15% share price gain to €10.25, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 23x in the Personal Products industry in Europe. Total loss to shareholders of 77% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €20.12 per share.お知らせ • Jul 02Herbalife Ltd. to Report Q2, 2024 Results on Jul 31, 2024Herbalife Ltd. announced that they will report Q2, 2024 results After-Market on Jul 31, 2024お知らせ • Jun 26Herbalife Ltd. Appoints Perkins Miller to Its Board of DirectorsHerbalife Ltd. welcomed experienced e-commerce and media technology executive Perkins Miller to its board of directors. Miller’s appointment as an independent director is effective June 26, 2024. Miller is the CEO of Fandom, the world’s largest fan platform where fans immerse themselves in imagined worlds across entertainment and gaming, where he has transformed the brand into an entertainment tech company, offering personalized experiences, targeted advertising, and in-depth fan insights. Miller has held executive leadership roles including General Manager of the Americas and Co-President, StubHub, Chief Digital Officer and Head of Media Operations, National Football League, Executive Vice President of Digital Media, WWE, and Head of Digital Media, NBC Sports and Olympics. Miller’s corporate board experience includes serving as an independent director at ISOS Capital Management.Recent Insider Transactions • May 07Independent Director recently bought €269k worth of stockOn the 3rd of May, Donal Mulligan bought around 30k shares on-market at roughly €8.96 per share. This transaction amounted to 60% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth €463k. Insiders have collectively bought €1.4m more in shares than they have sold in the last 12 months.お知らせ • May 03Herbalife Ltd. Provides Earnings Guidance for the Second Quarter of 2024 and Revises Earnings Guidance for the Full Year of 2024Herbalife Ltd. provided earnings guidance for the second quarter of 2024 and revised earnings guidance for the full year of 2024. For the quarter, the company expects net sales to be between 0% to 3% year-over-year.For the full year, the company expects net sales to be between 0% to 5% year-over-year against previous guidance of 0% to 5% year-over-year.Reported Earnings • May 02First quarter 2024 earnings released: EPS: US$0.24 (vs US$0.30 in 1Q 2023)First quarter 2024 results: EPS: US$0.24 (down from US$0.30 in 1Q 2023). Revenue: US$1.26b (up 1.0% from 1Q 2023). Net income: US$24.3m (down 17% from 1Q 2023). Profit margin: 1.9% (down from 2.3% in 1Q 2023). Revenue is forecast to grow 3.1% p.a. on average during the next 2 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has fallen by 41% per year, which means it is performing significantly worse than earnings.Valuation Update With 7 Day Price Move • Apr 05Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €6.96, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 19x in the Personal Products industry in Europe. Total loss to shareholders of 81% over the past three years.お知らせ • Apr 03Herbalife Ltd. to Report Q1, 2024 Results on May 01, 2024Herbalife Ltd. announced that they will report Q1, 2024 results After-Market on May 01, 2024Recent Insider Transactions • Mar 29Insider recently bought €140k worth of stockOn the 26th of March, Juan Mendoza bought around 16k shares on-market at roughly €8.68 per share. This transaction amounted to 58% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth €463k. Insiders have collectively bought €1.1m more in shares than they have sold in the last 12 months.お知らせ • Mar 20+ 1 more updateHerbalife Ltd. Announces Chief Financial Officer ChangesHerbalife Ltd. announced the appointment of John DeSimone as Chief Financial Officer, succeeding Alex Amezquita who will remain with the Company. Mr. DeSimone has been an executive at Herbalife for the past 17 years, including more than 8 years as CFO from 2010 – 2018 and 4 years as President and Co-President from 2018 – 2022. Most recently, he served as a Special Advisor to the CEO.お知らせ • Mar 07Herbalife Appoints Back Michael Levitt to Board of DirectorsHerbalife Ltd. announced the appointment of veteran finance executive, Michael Levitt, to its Board of Directors, effective March 1, 2024. Levitt previously served on the Company’s Board as the Lead Director from 2011 to 2014. Kevin Jones, who has served as a director since 2021, will step down from his role on the Board. Levitt is the Chairman of Irradiant Partners, LP, an investment management firm. He also serves as a member of the firm’s Management and Investment Committees. Prior to the launch of Irradiant Partners, he held various executive and leadership roles at several investment firms, including Kayne Anderson Capital Advisors, LP, Apollo Global Management, LLC, Smith Barney Inc. and Morgan Stanley & Co. Levitt has also served on multiple board of director positions. The Company and its Board of Directors extend sincere appreciation to Kevin Jones for his board service, valuable perspective, leadership, and commitment to Herbalife.Recent Insider Transactions • Feb 25Chairman & CEO recently bought €463k worth of stockOn the 16th of February, Michael Johnson bought around 62k shares on-market at roughly €7.49 per share. This transaction amounted to 15% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Michael's only on-market trade for the last 12 months.お知らせ • Feb 22Herbalife Ltd., Annual General Meeting, Apr 25, 2024Herbalife Ltd., Annual General Meeting, Apr 25, 2024, at 08:30 Pacific Standard Time.Valuation Update With 7 Day Price Move • Feb 21Investor sentiment deteriorates as stock falls 31%After last week's 31% share price decline to €7.58, the stock trades at a forward P/E ratio of 4x. Average forward P/E is 19x in the Personal Products industry in Europe. Total loss to shareholders of 80% over the past three years.New Risk • Feb 18New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 21% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.7x net interest cover). Negative equity (-US$1.1b). Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.8% net profit margin).Reported Earnings • Feb 15Full year 2023 earnings released: EPS: US$1.44 (vs US$3.26 in FY 2022)Full year 2023 results: EPS: US$1.44 (down from US$3.26 in FY 2022). Revenue: US$5.06b (down 2.7% from FY 2022). Net income: US$142.2m (down 56% from FY 2022). Profit margin: 2.8% (down from 6.2% in FY 2022). Revenue is forecast to grow 2.5% p.a. on average during the next 2 years, compared to a 5.4% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has fallen by 40% per year, which means it is performing significantly worse than earnings.お知らせ • Feb 08Herbalife Announces Launch of the Herbalife® GLP-1 Nutrition CompanionHerbalife announced the launch of the Herbalife® GLP-1 Nutrition Companion, a new range of food and supplement product combos fueled by the #1 Protein Shake in the World and intended to support the nutritional needs of individuals on GLP-1 and other weight-loss medications. Herbalife's Classic and Vegan options are now available in the United States and Puerto Rico in a variety of flavors. Recent research has shown that people taking GLP-1 weight-loss medications may experience decreases in muscle density and malnutrition. Herbalife is dedicated to addressing these nutritional deficiencies through the new combination that include nutrition products designed to deliver protein and fiber. Additionally, the Company's independent distributors create a supportive community to help consumers develop proper nutrition habits while on weight-loss drugs and maintain those habits after the drug treatment ends. The Herbalife GLP-1 Nutrition Companion includes: Classic Product Combo; Formula 1 Healthy Meal Nutritional Shake Mix (the #1 Protein Shake in the world); Protein Drink Mix; Active Fiber Complex; Vegan Product Combo; HERBALIFE V Plant-Based Digestive Support; HERBALIFE V plant-Based Digestive Support+; HERBALIFE V plants-Based Greens Booster. Each product combo provides vital protein to help build muscle tissue and maintain lean muscle mass while providing energy and fiber to promote regularity and a healthy digestive system. Additionally, the Classic combo delivers essential vitamins and minerals to support overall health, while the Vegan combo also delivers three organic blends of 20 fruits and vegetables.お知らせ • Jan 09Herbalife Ltd. to Report Q4, 2023 Results on Feb 14, 2024Herbalife Ltd. announced that they will report Q4, 2023 results After-Market on Feb 14, 2024Valuation Update With 7 Day Price Move • Jan 09Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €11.49, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 21x in the Personal Products industry in Europe. Total loss to shareholders of 72% over the past three years.New Risk • Nov 02New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 3.7% Last year net profit margin: 5.7% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.5x net interest cover). Negative equity (-US$1.1b). Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Profit margins are more than 30% lower than last year (3.7% net profit margin).Reported Earnings • Nov 02Third quarter 2023 earnings released: EPS: US$0.43 (vs US$0.84 in 3Q 2022)Third quarter 2023 results: EPS: US$0.43 (down from US$0.84 in 3Q 2022). Revenue: US$1.28b (down 1.1% from 3Q 2022). Net income: US$42.8m (down 48% from 3Q 2022). Profit margin: 3.3% (down from 6.3% in 3Q 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 31% per year, which means it is performing significantly worse than earnings.お知らせ • Oct 21Herbalife Appoints Claire V. Groen, to Chief Human Resource OfficerHerbalife announced that Claire V. Groen has been named the new Chief Human Resource Officer, effective immediately, and is reporting to executive vice president and Chief of Staff, Ibi Montesino. In this role Ms. Groen is responsible for Herbalife's global human resource strategy and function in support of Herbalife's overall business plan. This includes providing leadership in the areas of employee engagement and culture, talent acquisition and organization design and development, diversity and inclusion, employee relations, leadership development, employee education and training, compensation and benefits and human resource information systems. Ms. Groen is a global human resources leader with over 28 years' experience in the consumer goods and professional services industries. Before joining Herbalife, she was a senior advisor with the Boston Consulting Group and prior to that role, she held numerous leadership roles at Amway for more than 15 years, including legal counsel for human resources, vice president of Global Compensation and Benefits, Global Litigation, Governance and Legal HR, and most recently as the Chief People Officer. Ms. Groen earned a Bachelor of Arts in English Literature and Philosophy from Calvin University in Grand Rapids, Michigan, and a Juris Doctorate from Indiana University's Bloomington College of Law in Bloomington, Indiana.New Risk • Oct 13New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 8.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (8.2% average weekly change). Negative equity (-US$1.2b).お知らせ • Oct 06Herbalife Names Susan Brown as Head of Global Corporate CommunicationsHerbalife reported that Susan Brown has been named as Head of Global Corporate Communications, and is reporting to executive vice president and Chief of Staff, Ibi Montesino. In this role, Brown is responsible for Herbalife's communications function, leading the development and execution of all internal and external communications, overseeing corporate reputation, and advancing communications strategy in support of the company's business objectives. Brown is a global corporate communications leader with more than two decades of strategic, corporate and crisis communications experience. Prior to joining Herbalife, she was the head of global corporate communications for Tyson Foods and Price Waterhouse Coopers (PWC), and held communications leadership roles at SITA, an airlines IT provider, as well as Emirates Airline & Group. She brings strong international experience having lived and worked in Germany, the Netherlands, Switzerland, the United Arab Emirates and the United States.お知らせ • Oct 05Herbalife Ltd. to Report Q3, 2023 Results on Nov 01, 2023Herbalife Ltd. announced that they will report Q3, 2023 results After-Market on Nov 01, 2023お知らせ • Sep 15Herbalife Ltd. Appoints Rodica Macadrai to Board of DirectorsHerbalife Ltd. announced, as part of its governance process, the Herbalife Board of Directors has appointed independent distributor, Ms. Rodica Macadrai, as a new member to the Board, effective September 10, 2023. Ms. Macadrai became an Herbalife independent distributor in 1994 in Moldova, immediately after having earned a Doctor of Medicine in Psychology from Babes Bolyai University in Cluj Napoca, Romania. Over the past 29 years she has built a global business, across 50 markets in Europe, Asia-Pacific, North America, and Latin America. In 2020, she was named to the company’s Chairman’s Club, one of the top distributor levels. Ms. Macadrai is filling the Board of Director seat made vacant when Stephan Gratziani resigned from the Board on August 1, 2023, to become the company’s Chief Strategy Officer.Reported Earnings • Aug 03Second quarter 2023 earnings released: EPS: US$0.60 (vs US$0.88 in 2Q 2022)Second quarter 2023 results: EPS: US$0.60 (down from US$0.88 in 2Q 2022). Revenue: US$1.31b (down 5.7% from 2Q 2022). Net income: US$59.9m (down 31% from 2Q 2022). Profit margin: 4.6% (down from 6.2% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 30% per year, which means it is performing significantly worse than earnings.お知らせ • Aug 03Herbalife Ltd. Announces Management ChangesHerbalife Ltd. announced the appointment of Stephan Paulo Gratziani to Chief Strategy Officer, effective August 4, 2023. Mr. Gratziani will report directly to Chairman and Chief Executive Officer Michael Johnson and work closely with the Company’s senior management team to implement and advance key strategic initiatives, including the Herbalife One digital technology platform and business verticals. He will also partner with senior executive and regional leadership to enhance sales training programs, promote distributor engagement, and identify growth opportunities. Mr. Gratziani brings over 32 years of experience to Herbalife as an independent distributor with a proven track record of global business growth. During his time as an independent distributor, Gratziani expanded his Herbalife business to 70 markets across North America, South America, Europe, and Asia. He was named to the Company’s Chairman’s Club in 2010, and in 2018, he achieved the highest distributor level of Founder’s Circle. Mr. Gratziani was also recognized as one of Herbalife’s top 3 independent distributors in the world for 2022. As a distributor leader, he has been an integral member of various strategy and planning groups for the Company and brings a strong analytics background and innovative entrepreneurism. Additionally, John DeSimone will transition from his position as Chief Strategic Officer to Special Advisor to the Company. On August 1, 2023, Mr. Gratziani resigned from the Company’s Board of Directors and agreed to become an employee of the Company in the role of Chief Strategy Officer. As required by the Company’s conflict of interest policy, Mr. Gratziani agreed to suspend his Herbalife distributorship and waived any rights to his distributorship earnings under the Company’s marketing plan during the term of his employment with the Company through December 31, 2025.お知らせ • Aug 01Herbalife Introduces Herbalife V, New Product Line to Meet Increased Consumer Demand for Plant-Based OptionsHerbalife introduced Herbalife V, its latest science-based product line, to better support consumers seeking plant-based options to benefit their overall health. According to studies, plant-based lifestyles are on the rise. In fact, approximately 3% of Americans consider themselves vegan, up from 2% in 2012, while 5% are vegetarian. Additionally, almost half of Americans call themselves flexitarians. Herbalife V is backed by science and rigorously tested for quality. All products are certified USDA Organic, non-GMO-verified, Kosher, and Plant-based and Vegan by FoodChain ID. Additionally, they are formulated with no soy or dairy and made with no artificial sweeteners or flavors. The product line offers five plant-based certified products that help simplify plant-based nutrition, including: Plant-based Protein Shakes vailable in classic and chocolate flavors and formulated with 20 grams of protein (pea, pumpkin seeds, and chia).Help satisfy hunger, reduce food cravings, maintain lean muscle tone, and are an excellent source of non-heme iron. Sustain energy and promote healthy skin. Greens Booster Formulated with special blends derived from organic fruits, vegetables, superfood powders, and green tea. An easy way to add more fruits and vegetables to daily routine. Immune Support Contains vitamins C, D, and zinc to help balance and support daily immune health. Digestive Support Oat and guar fibers support a healthy gut and digestion and regularity. Herbalife V is available in the U.S. and Puerto Rico exclusively through Herbalife independent distributors. Click here to learn more about this product.Valuation Update With 7 Day Price Move • Jul 25Investor sentiment improves as stock rises 24%After last week's 24% share price gain to €14.34, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 22x in the Personal Products industry in Europe. Total loss to shareholders of 67% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €22.41 per share.お知らせ • Jul 06Herbalife Ltd. to Report Q2, 2023 Results on Aug 02, 2023Herbalife Ltd. announced that they will report Q2, 2023 results After-Market on Aug 02, 2023Valuation Update With 7 Day Price Move • May 26Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to €10.59, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 21x in the Personal Products industry in Europe. Total loss to shareholders of 73% over the past three years.Recent Insider Transactions • May 11Insider recently bought €300k worth of stockOn the 8th of May, Stephan Gratziani bought around 24k shares on-market at roughly €12.76 per share. This transaction increased Stephan Gratziani's direct individual holding by 2x at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €1.5m more in shares than they have sold in the last 12 months.お知らせ • May 04Herbalife Ltd. Announces Executive Changes, Effective July 1, 2023Herbalife Ltd. announced senior executive leadership changes. As part of its succession management process, the Company announced Mark Schissel's retirement after 16 years of leadership contributions on July 1. Frank Lamberti will be appointed to Chief Operating Officer. In addition, the Company is announced the expanded role of Ibi Montesino, EVP and Chief of Staff, and the appointment of Rob Levy to Regional President of the Americas. All three executives will assume their roles effective July 1, 2023 and report directly to Michael Johnson, Chief Executive Officer. Schissel will assume a strategic advisory role to help ensure a smooth transition and will continue to work on special projects. In Lamberti's new role, he will oversee product innovation and supply chain, digital content and infrastructure, distributor and sales analytics, as well as back office operations. Lamberti joined Herbalife in 2005 as vice president of investor relations and has served in numerous leadership positions, including most recently, as Regional President of the Americas working closely with distributors and their customers. Prior to that, he served as executive vice president, Distributor Customer experience. He also worked internationally as senior vice president and managing director, North Asia. Montesino's expanded role will encompass all global distributor facing business including sales, marketing and distributor operation functions, as well as all aspects of employee management and relations. She joined the Company in 1998 as an assistant for personal care and then transitioned to product marketing before joining the NAM region where she served in multiple capacities including director, senior director, vice president of sales and marketing for the U.S. Latin market and eventually leading the entire North America market. Currently, as executive vice president of distributor and customer experience, she oversees functions that develop and deliver innovative tools and programs that support independent distributors and their customers. Rob Levy has been appointed Regional President of the Americas and will be responsible for all strategic, sales and marketing functions across the region. As head of the Americas, his oversight includes North America, South and Central America, Mexico and Brazil. Levy, a longtime Herbalife industry veteran with 28 years at the Company, has run every region during his tenure, and was key to the Company's expansion to half the markets the Company has today. He is currently serving as EVP Worldwide Distributor Affairs.Reported Earnings • May 03First quarter 2023 earnings released: EPS: US$0.30 (vs US$0.98 in 1Q 2022)First quarter 2023 results: EPS: US$0.30 (down from US$0.98 in 1Q 2022). Revenue: US$1.25b (down 6.3% from 1Q 2022). Net income: US$29.3m (down 70% from 1Q 2022). Profit margin: 2.3% (down from 7.4% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings.Recent Insider Transactions • Feb 27Independent Director recently bought €273k worth of stockOn the 22nd of February, Donal Mulligan bought around 15k shares on-market at roughly €18.17 per share. This transaction amounted to 83% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €2.6m more in shares than they have sold in the last 12 months.Valuation Update With 7 Day Price Move • Feb 21Investor sentiment improves as stock rises 23%After last week's 23% share price gain to €18.90, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 24x in the Personal Products industry in Europe. Total loss to shareholders of 44% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €10.81 per share.Reported Earnings • Feb 15Full year 2022 earnings released: EPS: US$3.26 (vs US$4.22 in FY 2021)Full year 2022 results: EPS: US$3.26 (down from US$4.22 in FY 2021). Revenue: US$5.20b (down 10% from FY 2021). Net income: US$321.3m (down 28% from FY 2021). Profit margin: 6.2% (down from 7.7% in FY 2021). The decrease in margin was driven by lower revenue. Revenue is expected to decline by 1.2% p.a. on average during the next 2 years, while revenues in the Personal Products industry in Europe are expected to grow by 5.0%. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.お知らせ • Jan 18Herbalife Nutrition Ltd. to Report Q4, 2022 Results on Feb 14, 2023Herbalife Nutrition Ltd. announced that they will report Q4, 2022 results at 4:00 PM, US Eastern Standard Time on Feb 14, 2023お知らせ • Nov 01+ 2 more updatesHerbalife Nutrition Ltd. Withdraws Earnings Guidance for the Year 2022Herbalife Nutrition Ltd. Withdraws earnings guidance for the year 2022. Given the rapidly shifting macroeconomic sentiment and backdrop, as well as increased volatility in the marketplace, the Company is withdrawing Fiscal Year 2022 guidance. The Company will periodically reassess its ability to provide guidance when it believe future performance can be reasonably estimated.お知らせ • Oct 04Herbalife Nutrition Ltd. to Report Q3, 2022 Results on Oct 31, 2022Herbalife Nutrition Ltd. announced that they will report Q3, 2022 results at 4:00 PM, US Eastern Standard Time on Oct 31, 2022Reported Earnings • Aug 03Second quarter 2022 earnings released: EPS: US$0.88 (vs US$1.34 in 2Q 2021)Second quarter 2022 results: EPS: US$0.88 (down from US$1.34 in 2Q 2021). Revenue: US$1.39b (down 10% from 2Q 2021). Net income: US$86.5m (down 40% from 2Q 2021). Profit margin: 6.2% (down from 9.3% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is expected to shrink by 1.7% compared to a 7.7% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.お知らせ • Aug 03Herbalife Nutrition Ltd. Provides Revenue Guidance for the Three Months Ending September 30, 2022 and Twelve Months Ending December 31, 2022Herbalife Nutrition Ltd. provided revenue guidance for the three months ending September 30, 2022 and twelve months ending December 31, 2022. For the three months ending September 30, 2022, negative net sales growth (Decline) is in the range of 9% to 3%. For the twelve months ending December 31, 2022, negative net sales growth (Decline) is in the range of 10% to 4%.Valuation Update With 7 Day Price Move • Jul 19Investor sentiment improved over the past weekAfter last week's 16% share price gain to €22.45, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 26x in the Personal Products industry in Europe. Total loss to shareholders of 39% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €26.61 per share.お知らせ • Jul 17Herbalife Nutrition Introduces a New Product to Help Consumers Get Back on Track with Their Healthy LifestyleHerbalife Nutrition introduced its latest science-backed product, Fat Release, to support its consumers' healthy and active lifestyles. According to a recent U.S.study by OnePoll, the average person overindulges in unhealthy food three nights per week, and when a person is working to maintain a healthy lifestyle or on a weight loss journey, overindulging affects their health goals. This product helps trim the fat from food to keep consumers on track with their health goals. While this new product is not a stand-alone weight loss product, it can be helpful to consumers who indulge and have fatty foods as part of a meal, if consumed within two hours of the meal. Fat Release is formulated with Litramine®, the beneficial ingredient in the product, which is derived from prickly pear and is a patented cactus fiber ingredient that helps trim the fat from food. The Fruit Twist flavor powdered stick pack contains 30 single servings and can be consumed straight from the pack, no water required or added to 8 fl. oz. of hot or cold water.お知らせ • Jul 06Herbalife Nutrition Ltd. to Report Q2, 2022 Results on Aug 02, 2022Herbalife Nutrition Ltd. announced that they will report Q2, 2022 results at 4:00 PM, US Eastern Standard Time on Aug 02, 2022お知らせ • May 04Herbalife Nutrition Ltd. Provides Earnings Guidance for the Three Months Ending June 30, 2022 and Twelve Months Ending December 31, 2022Herbalife Nutrition Ltd. provided earnings guidance for the three months ending June 30, 2022 and twelve months ending December 31, 2022. For the three months, the company expects negative net sales growth vs 2021 in the range of 17.5% and 11.5%.For the twelve months, the company expects negative net sales growth vs 2021 in the range of 10% and 4%.お知らせ • Apr 06Herbalife Nutrition Ltd. to Report Q1, 2022 Results on May 03, 2022Herbalife Nutrition Ltd. announced that they will report Q1, 2022 results After-Market on May 03, 2022お知らせ • Feb 25Herbalife Nutrition Ltd., Annual General Meeting, Apr 27, 2022Herbalife Nutrition Ltd., Annual General Meeting, Apr 27, 2022.お知らせ • Feb 24Herbalife Nutrition Ltd. Provides Earnings Guidance for the First Quarter Ending March 31, 2022 and Full Year Ending December 31, 2022Herbalife Nutrition Ltd. provided earnings guidance for the first quarter ending March 31, 2022 and full year ending December 31, 2022. For the quarter, the company expects negative net sales guidance range of 10% - 4% growth.For the year, the company initiating Fiscal Year 2022 net sales guidance range of 0% - 6% growth.Reported Earnings • Feb 24Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: US$4.22 (up from US$2.83 in FY 2020). Revenue: US$5.80b (up 4.7% from FY 2020). Net income: US$447.2m (up 20% from FY 2020). Profit margin: 7.7% (up from 6.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to stay flat compared to a 8.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 03Third quarter 2021 earnings released: EPS US$1.11 (vs US$1.07 in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: US$1.43b (down 6.0% from 3Q 2020). Net income: US$117.4m (down 15% from 3Q 2020). Profit margin: 8.2% (down from 9.1% in 3Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.Recent Insider Transactions • Sep 22Chairman & CEO recently bought €191k worth of stockOn the 17th of September, John Agwunobi bought around 5k shares on-market at roughly €38.25 per share. In the last 3 months, they made an even bigger purchase worth €212k. John has been a buyer over the last 12 months, purchasing a net total of €403k worth in shares.Valuation Update With 7 Day Price Move • Sep 16Investor sentiment deteriorated over the past weekAfter last week's 21% share price decline to €36.06, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 33x in the Personal Products industry in Europe. Total loss to shareholders of 22% over the past three years.お知らせ • Sep 15Herbalife Nutrition Lowers Third Quarter and Full Year 2021 GuidanceHerbalife Nutrition Ltd. announced that it is revising its third quarter and full year 2021 guidance. Recently, the Company observed lower than expected levels of activity amongst its independent distributors that has led to a decrease in expected third quarter and full year net sales. Despite this, the company anticipates net sales growth in the third quarter to be between approximately 14% to 18% versus third quarter 2019 and growth for the full year to be between approximately 19% to 23% versus full year 2019.株主還元HOODE Personal ProductsDE 市場7D-0.7%4.3%1.6%1Y54.4%-6.7%2.2%株主還元を見る業界別リターン: HOO過去 1 年間で-6.7 % の収益を上げたGerman Personal Products業界を上回りました。リターン対市場: HOO過去 1 年間で2.2 % の収益を上げたGerman市場を上回りました。価格変動Is HOO's price volatile compared to industry and market?HOO volatilityHOO Average Weekly Movement7.4%Personal Products Industry Average Movement5.2%Market Average Movement6.0%10% most volatile stocks in DE Market13.2%10% least volatile stocks in DE Market2.7%安定した株価: HOO 、 German市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: HOOの 週次ボラティリティ ( 7% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト19808,500Stephan Gratzianiwww.herbalife.comハーバライフ・リミテッドはその子会社とともに、北米、メキシコ、中南米、ヨーロッパ、中東、アフリカ、中国、アジア太平洋地域で健康とウェルネス製品を提供している。同社は、体重管理、目標栄養、エネルギー、スポーツ、フィットネス、外部栄養、文献、販売促進、その他の分野で製品を提供している。また、ミールリプレイスメント製品、プロテインシェイク、ドリンクミックス、減量サプリメント、健康的なスナック、代謝を高めるお茶などの体重管理製品、機能性飲料、ハーブ、ビタミン、ミネラル、その他の天然成分を含む栄養補助食品からなる標的栄養製品、フェイシャルスキン、ボディ、ヘアケア製品などの外側からの栄養製品、N-R-Gティーやエナジードリンク製品などのエネルギー、スポーツ、フィットネス製品も提供している。さらに、スタートアップキット、販売ツール、教育教材からなる文献、プロモーション、その他の資料も提供している。同社は販売代理店、独立系サービスプロバイダー、同社が運営する小売店やプラットフォームを通じて製品を販売している。以前はハーバライフ・ニュートリション・リミテッドとして知られていたが、2023年4月にハーバライフ・リミテッドに社名を変更した。ハーバライフ・リミテッドは1980 年に設立され、カリフォルニア州ロサンゼルスに本社を置く。もっと見るHerbalife Ltd. 基礎のまとめHerbalife の収益と売上を時価総額と比較するとどうか。HOO 基礎統計学時価総額€1.08b収益（TTM）€206.23m売上高(TTM)€4.41b5.3xPER（株価収益率0.2xP/SレシオHOO は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計HOO 損益計算書（TTM）収益US$5.13b売上原価US$1.14b売上総利益US$3.99bその他の費用US$3.75b収益US$239.80m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）2.31グロス・マージン77.78%純利益率4.67%有利子負債／自己資本比率-458.6%HOO の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/27 07:52終値2026/05/27 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Herbalife Ltd. 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。16 アナリスト機関John StaszakArgus Research CompanyMeredith AdlerBarclaysBrian WangBarclays13 その他のアナリストを表示
Recent Insider Transactions • May 25Chief Operating Officer recently sold €452k worth of stockOn the 19th of May, Troy Hicks sold around 41k shares on-market at roughly €11.12 per share. This transaction amounted to 91% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €1.6m. This was Troy's only on-market trade for the last 12 months.
Recent Insider Transactions • May 20Chief Commercial Officer recently sold €1.6m worth of stockOn the 12th of May, Frank Lamberti sold around 143k shares on-market at roughly €11.53 per share. This transaction amounted to 80% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €1.5m more than they bought in the last 12 months.
お知らせ • Apr 01Herbalife Ltd. to Report Q1, 2026 Results on May 06, 2026Herbalife Ltd. announced that they will report Q1, 2026 results After-Market on May 06, 2026
お知らせ • Mar 18Herbalife Ltd., Annual General Meeting, Apr 30, 2026Herbalife Ltd., Annual General Meeting, Apr 30, 2026. Location: 800 w. olympic blvd, suite 406, los angeles, ca 90015, United States
お知らせ • Feb 19+ 1 more updateHerbalife Ltd. Provides Earnings Guidance for the First Quarter and Full Year 2026Herbalife Ltd. provided earnings guidance for the first quarter and full year 2026. For the quarter, The company expects reported net sales from +3.0% to +7.0% year-over-year. For the year, The company expects reported net sales from +1.0% to +6.0% year-over-year.
お知らせ • Jan 05Herbalife Ltd. to Report Q4, 2025 Results on Feb 18, 2026Herbalife Ltd. announced that they will report Q4, 2025 results After-Market on Feb 18, 2026
Recent Insider Transactions • May 25Chief Operating Officer recently sold €452k worth of stockOn the 19th of May, Troy Hicks sold around 41k shares on-market at roughly €11.12 per share. This transaction amounted to 91% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €1.6m. This was Troy's only on-market trade for the last 12 months.
Recent Insider Transactions • May 20Chief Commercial Officer recently sold €1.6m worth of stockOn the 12th of May, Frank Lamberti sold around 143k shares on-market at roughly €11.53 per share. This transaction amounted to 80% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €1.5m more than they bought in the last 12 months.
お知らせ • Apr 01Herbalife Ltd. to Report Q1, 2026 Results on May 06, 2026Herbalife Ltd. announced that they will report Q1, 2026 results After-Market on May 06, 2026
お知らせ • Mar 18Herbalife Ltd., Annual General Meeting, Apr 30, 2026Herbalife Ltd., Annual General Meeting, Apr 30, 2026. Location: 800 w. olympic blvd, suite 406, los angeles, ca 90015, United States
お知らせ • Feb 19+ 1 more updateHerbalife Ltd. Provides Earnings Guidance for the First Quarter and Full Year 2026Herbalife Ltd. provided earnings guidance for the first quarter and full year 2026. For the quarter, The company expects reported net sales from +3.0% to +7.0% year-over-year. For the year, The company expects reported net sales from +1.0% to +6.0% year-over-year.
お知らせ • Jan 05Herbalife Ltd. to Report Q4, 2025 Results on Feb 18, 2026Herbalife Ltd. announced that they will report Q4, 2025 results After-Market on Feb 18, 2026
お知らせ • Nov 13Herbalife Expands Liftoff Energy Line with New Cola and Ginger Beer FlavorsHerbalife announced the expansion of its Liftoff energy product line with two new flavors: Cola and Ginger Beer. The zero-sugar, low-calorie mental-focus and energy-boosting supplement combines the effervescent taste of classic soda with science-backed ingredients. Available exclusively through Herbalife's Independent Distributors, the new flavors come in convenient stick packs for active, on-the-go consumers and are available exclusively in the United States and Puerto Rico. Herbalife expands its Liftoff energy line with two new soda-inspired flavors, Cola and Ginger Beer, available in convenient stick packs through Herbalife Independent Distributors in the United States and Puerto Puerto Rico. The U.S. energy drink market is projected to grow to $41.4 billion by 2033 driven by rising demand for functional beverages1. Amid that growth and since its introduction in 2005, Liftoff stands out as a low-calorie option that combines popular flavors with science-backed nutrition. Each serving contains 75 mg of caffeine to feel energized and focused, Panax ginseng to support mental alertness+, vitamin C for antioxidant protection, and a full spectrum of B vitamins for energy metabolism support. Liftoff is ranked among Herbalife's top-selling products. Its popularity is driven by the company's large network of Independent Distributors and their customers who trust and enjoy the product because of its proven benefits. The success of Liftoff can be attributed to its heavy adoption in the community of Herbalife's network of over 10,000 nutrition clubs in the U.S. These independently owned health and wellness centers provide a space where consumers can connect with a community of like-minded people, health-focused products, and receive personalized support. At nutrition clubs, Liftoff is a popular selection that supports overall health and wellness goals. Herbalife also offers Herbalife24 Liftoff as part of its sports nutrition line, developed to meet the energy, hydration and recovery needs of athletes and active individuals. The Herbalife24 line is NSF Certified for Sport®?++, a third-party certification that confirms products meet the highest standards for quality, safety, and competitive use, giving professional athletes confidence in their performance nutrition choices. Liftoff is available in more than 65 markets worldwide and continues to be a core part of Herbalife's functional energy portfolio. Earlier this year, Liftoff launched in India with a new Watermelon flavor, marking the brand's first entry into that region. Globally, the Liftoff line features more than 10 flavors, reflecting Herbalife's commitment to delivering functional, science-backed energy solutions tailored to local consumer preferences.
お知らせ • Nov 06+ 1 more updateHerbalife Ltd. Revises Earnings Guidance for the Full-Year 2025Herbalife Ltd. revised earnings guidance for the Full-Year 2025. For the period, Company now expects Net Sales in the range of (0.3)% to +0.7% YoY against previous guidance of (1.0)% to +3.0% YoY.
お知らせ • Oct 01Herbalife Ltd. to Report Q3, 2025 Results on Nov 05, 2025Herbalife Ltd. announced that they will report Q3, 2025 results After-Market on Nov 05, 2025
お知らせ • Aug 07+ 1 more updateHerbalife Ltd. Revises Earnings Guidance for Full Year of 2025Herbalife Ltd. revised earnings guidance for full year of 2025. For the period, the company now expects net sales of negative 1.0% to positive 2.5% year on year as compared to previous guidance of negative 2.5% to positive 2.5% Year on year.
お知らせ • Jul 07Herbalife Ltd. Launches MultiBurn™?Herbalife Ltd. announced the launch of MultiBurn™? -- a next-generation multi-action dietary supplement designed with clinically studied botanical extracts to support key areas of metabolic health. Formulated by Herbalife's global team of scientists and nutrition experts, MultiBurn™? is gluten-free, suitable for vegans and made without synthetic colors or dyes, reflecting the company's commitment to clean-label, user-friendly wellness solutions. As consumers continue to seek weight loss solutions, Herbalife offers an innovative, non-pharmaceutical approach with MultiBurn™?, a product grounded in science-backed ingredients and a continued commitment to wellness innovation. Built on a foundation of clinical research, MultiBurn™? features a powerful blend of three botanical ingredients: Morosil™? (from Moro blood oranges): supports overall weight loss, including reduced hip and waist interference and a healthy BMI ++. Metabolaid®? (hibiscus and lemon Verbena extract): helps with healthy reduction of fat and increased feeling of fullness after meals ++. Capsifen™? (red chili pepper and fenugreek blend): supports healthy energy expenditure. MultiBurn™? also contains supporting functional ingredients, including caffeine to stimulate metabolism and provide a feeling of energy and alertness, and chromium to aid in maintaining blood sugar levels already within the normal range. It can also be integrated into a broader Herbalife routine, complementing products such as high-protein shakes, fiber supplements and targeted wellness solutions -- all supported by Herbalife's global community of Independent Distributors who provide personalized guidance to millions of customers to achieve their weight loss and wellness goals. For 45 years, Herbalife has been committed to personalized nutrition and science-backed wellness. The company's very first product, Formula 1 Healthy Meal Nutritional Shake Mix, revolutionized meal replacement nutrition and is the #1 protein shake in the world -- sold in over 90 countries and trusted by millions. Recognized as the #1 active and lifestyle nutrition brand in the world2, Herbalife offers an extensive portfolio of products designed to support healthy weight management, sports performance, daily nutrition and promote skin and body care to help individuals at every stage of their wellness journey. MultiBurn™? builds on this legacy as part of Herbalife's ongoing evolution, bringing together clinical research, ingredient transparency and innovative formulation to address the modern consumer demand for whole-person wellness. MultiBurn™? is now available in the United States, and will be launching in Puerto Rico in September 2025. For more information on MultiBurn™?, please click here. Herbalife products are available exclusively through Herbalife Independent Distributors. To purchase Herbalife's MultiBurn™? in the United States or Puerto Rico, consumers can call 1-888-443-7225. For specific questions about using Herbalife products with other weight-loss therapies, contact Herbalife's dedicated team of health and safety professionals at . These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.++ In combination with a healthy diet and active lifestyle.
お知らせ • Jul 02Herbalife Ltd. to Report Q2, 2025 Results on Aug 06, 2025Herbalife Ltd. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025
お知らせ • Jun 30+ 2 more updatesHerbalife Ltd.(NYSE:HLF) dropped from Russell 2000 Growth-Defensive IndexHerbalife Ltd.(NYSE:HLF) dropped from Russell 2000 Growth-Defensive Index
お知らせ • Jun 12Herbalife Ltd’s Aloin Identification Method for Aloe Vera Officially Recognized by AOAC INTERNATIONALHerbalife Ltd. announced the Association of Official Analytical Collaboration (AOAC INTERNATIONAL)—a global authority in analytical science—has formally certified its proprietary method for identifying and measuring anthraquinones, also known as aloins, in aloe vera. Aloe regulatory groups require producers of ingestible aloe vera products to monitor naturally occurring compounds such as aloin A, aloin B, and aloe-emodin to meet safety guidelines. This certification officially recognizes Herbalife’s longstanding method as the world’s first AOAC-approved approach for detecting aloins—reinforcing safety and quality benchmarks across botanical and dietary supplement industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250611798277/en/. Developed by Herbalife scientists and validated by independent laboratories worldwide, this AOAC-certified method is used to test every batch of Herbalife’s aloe-based products, ensuring safety, while preserving aloe vera’s natural benefits. Aloe vera is a key ingredient in many of Herbalife’s top products, which are sold in more than 90 markets. Herbalife’s method was validated through a global multi-laboratory study involving eight independent laboratories. Each lab tested the same set of six aloe vera samples, including both raw materials and finished products, using HPLC (High-Performance Liquid Chromatography) to measure aloin A, aloin B, and aloe-emodin. The study ensured the method's accuracy and reliability across various labs and product types, with results confirming that it met all performance criteria, including precision and system suitability. Herbalife has a long-standing commitment to aloe vera research and quality assurance. This dedication has resulted in five patents and three published studies focused on developing safe extraction methods that preserve the plant’s natural benefits. While many companies rely solely on supplier certifications to confirm the authenticity of their aloe vera, Herbalife goes further. The company is one of the few in the world using advanced proton nuclear magnetic resonance (NMR) spectrometry—an analytical technique that uses magnetic fields and radio waves to identify the molecular structure of raw materials. This allows Herbalife to independently verify the identity and purity of its aloe vera at the molecular level, ensuring the highest standards of quality, consistency and traceability across its global supply chain.
お知らせ • May 01+ 2 more updatesHerbalife Ltd. (NYSE:HLF) completed the acquisition of The assets of Pro2col Health.Herbalife Ltd. (NYSE:HLF) signed a letter of intent to acquire The assets of Pro2col Health on March 12, 2025. In related transactions Herbalife Ltd. also entered into a binding memorandum of understanding to acquire 100% of the assets of Pruvit Ventures and to acquire 51% stake in Link BioSciences Inc. The transactions will cost approximately $25 million to $30 million, with additional conditional payments possible based on future performance. The expected completion of the transaction is in the second quarter of 2025. Herbalife Ltd. (NYSE:HLF) completed the acquisition of The assets of Pro2col Health in April, 2025.
お知らせ • Apr 26Herbalife Ltd. Elects Lynda Cloud to Its Board of Directors, Effective April 23, 2025Herbalife Ltd. announced the election of Lynda Cloud to its Board of Directors, effective April 23, 2025. This appointment reflects Herbalife’s continued commitment to innovation, digital transformation, and personalized wellness. Lynda Cloud’s decades of leadership across education, technology, and health sectors make her uniquely equipped to support Herbalife’s next chapter. Her deep expertise in digital learning, consumer experience, and scalable education aligns with Herbalife’s strategic priorities to modernize, expand personalized wellness offerings, and build stronger, more connected communities across its global platform. Ms. Cloud brings nearly 30 years of leadership experience. Most recently, she served as CEO of the Institute for Integrative Nutrition (IIN), where she led a major global expansion of digital wellness education. Her previous leadership roles include CEO of Equal Ed and Executive Vice President at K12 Inc., where she spearheaded innovation in online learning and virtual school development.
お知らせ • Apr 01Herbalife Ltd. to Report Q1, 2025 Results on Apr 30, 2025Herbalife Ltd. announced that they will report Q1, 2025 results After-Market on Apr 30, 2025
お知らせ • Mar 13+ 2 more updatesHerbalife Ltd. (NYSE:HLF) entered into a binding memorandum of understanding to acquire the assets of Pruvit Ventures, Inc.Herbalife Ltd. (NYSE:HLF) entered into a binding memorandum of understanding acquire to the assets of Pruvit Ventures, Inc. on March 12, 2025. In related transactions Herbalife Ltd. also entered into a binding memorandum of understanding to acquire 100% of the assets of Pro2col Health LLC and to acquire 51% stake in Link BioSciences Inc. The transactions will cost approximately $25 million to $30 million, with additional conditional payments possible based on future performance. The expected completion of the transaction is in the second quarter of 2025.
お知らせ • Feb 21Herbalife Ltd. Provides Earnings Guidance for the First Quarter and Full Year 2025Herbalife Ltd. provided earnings guidance for the first quarter and full year 2025. For the quarter, the company expected Net sales from negative 5.5% to negative 1.5% year-over-year. For the year, the company expected Net sales from negative 3% to positive 3% year-over-year.
お知らせ • Feb 20+ 1 more updateHerbalife Ltd Announces Executive ChangesHerbalife Ltd. announced that Michael Johnson, current CEO and Chairman of the Board, will transition to Executive Chairman. As part of the planned leadership transition, Herbalife Managing Director of International Markets, Rob Levy, will take on the role of President, Worldwide Markets, also effective May 1, 2025. Mr. Levy has held several senior leadership roles and has led every region during his 30-year tenure with Herbalife. In his current role, Mr. Levy is responsible for all business, strategy, sales, and marketing functions across 43 markets internationally as well as international expansion. All Regional Managing Directors will report to Mr. Levy.
お知らせ • Jan 03Herbalife Ltd. to Report Q4, 2024 Results on Feb 19, 2025Herbalife Ltd. announced that they will report Q4, 2024 results on Feb 19, 2025
Valuation Update With 7 Day Price Move • Nov 06Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €7.31, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 20x in the Personal Products industry in Europe. Total loss to shareholders of 80% over the past three years.
お知らせ • Nov 02+ 1 more updateHerbalife Ltd. Provides Earnings Guidance for the Fourth Quarter of 2024Herbalife Ltd. provided earnings guidance for the Fourth quarter of 2024. For the quarter, the company expects net sales to be between at negative 3.0% to positive 1.0% year-over-year.
Reported Earnings • Nov 01Third quarter 2024 earnings released: EPS: US$0.47 (vs US$0.43 in 3Q 2023)Third quarter 2024 results: EPS: US$0.47 (up from US$0.43 in 3Q 2023). Revenue: US$1.24b (down 3.2% from 3Q 2023). Net income: US$47.4m (up 11% from 3Q 2023). Profit margin: 3.8% (up from 3.3% in 3Q 2023). Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 49% per year whereas the company’s share price has fallen by 44% per year.
お知らせ • Oct 01Herbalife Ltd. to Report Q3, 2024 Results on Oct 30, 2024Herbalife Ltd. announced that they will report Q3, 2024 results After-Market on Oct 30, 2024
Valuation Update With 7 Day Price Move • Sep 10Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to €6.15, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 23x in the Personal Products industry in Europe. Total loss to shareholders of 84% over the past three years.
Valuation Update With 7 Day Price Move • Aug 07Investor sentiment deteriorates as stock falls 24%After last week's 24% share price decline to €8.60, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 21x in the Personal Products industry in Europe. Total loss to shareholders of 79% over the past three years.
New Risk • Aug 01New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 29% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Negative equity (-US$1.0b). Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.6% net profit margin).
Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: US$0.047 (vs US$0.60 in 2Q 2023)Second quarter 2024 results: EPS: US$0.047 (down from US$0.60 in 2Q 2023). Revenue: US$1.28b (down 2.5% from 2Q 2023). Net income: US$4.70m (down 92% from 2Q 2023). Profit margin: 0.4% (down from 4.6% in 2Q 2023). Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 35% per year, which means it has not declined as severely as earnings.
お知らせ • Aug 01Herbalife Ltd. Provides Earnings Guidance for the Third Quarter of 2024 and Revised Earnings Guidance for the Full Year of 2024Herbalife Ltd. provided earnings guidance for the third quarter of 2024 and revised earnings guidance for the full year of 2024. For the quarter, the company expects net sales to be between (4.5)% to 0% year-over-year. For the full year, the company expects net sales to be between (3.5)% to 1.5% year-over-year against previous guidance of 0% to 5% year-over-year.
お知らせ • Jul 23Herbalife Introduces Protein Chips, A New Nutritious Snack Option to Meet Increased Consumer Demand for Protein FoodsHerbalife introduced Protein Chips in the United States and Puerto Rico. Protein Chips are the Company's latest protein snack offering, providing consumers with a healthy, savory and convenient way to help meet their daily nutrition goals. With consumers seeking more convenient and savory ways to integrate protein into their diets, especially as snacking replaces conventional meals among younger demographics, protein foods have been gaining traction. Protein Chips are backed by science and rigorously tested for quality. They are available in mild barbeque flavor and come in convenient on-the-go packs. Protein Chips are Gluten-Free Certified, suitable for vegetarians, toasted, not fried and contain: 8 grams of plant-based pea protein; Natural flavor; No cholesterol. Protein Chips are available exclusively through Herbalife independent distributors. Click here to learn more about this product.
Valuation Update With 7 Day Price Move • Jul 17Investor sentiment improves as stock rises 15%After last week's 15% share price gain to €10.25, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 23x in the Personal Products industry in Europe. Total loss to shareholders of 77% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €20.12 per share.
お知らせ • Jul 02Herbalife Ltd. to Report Q2, 2024 Results on Jul 31, 2024Herbalife Ltd. announced that they will report Q2, 2024 results After-Market on Jul 31, 2024
お知らせ • Jun 26Herbalife Ltd. Appoints Perkins Miller to Its Board of DirectorsHerbalife Ltd. welcomed experienced e-commerce and media technology executive Perkins Miller to its board of directors. Miller’s appointment as an independent director is effective June 26, 2024. Miller is the CEO of Fandom, the world’s largest fan platform where fans immerse themselves in imagined worlds across entertainment and gaming, where he has transformed the brand into an entertainment tech company, offering personalized experiences, targeted advertising, and in-depth fan insights. Miller has held executive leadership roles including General Manager of the Americas and Co-President, StubHub, Chief Digital Officer and Head of Media Operations, National Football League, Executive Vice President of Digital Media, WWE, and Head of Digital Media, NBC Sports and Olympics. Miller’s corporate board experience includes serving as an independent director at ISOS Capital Management.
Recent Insider Transactions • May 07Independent Director recently bought €269k worth of stockOn the 3rd of May, Donal Mulligan bought around 30k shares on-market at roughly €8.96 per share. This transaction amounted to 60% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth €463k. Insiders have collectively bought €1.4m more in shares than they have sold in the last 12 months.
お知らせ • May 03Herbalife Ltd. Provides Earnings Guidance for the Second Quarter of 2024 and Revises Earnings Guidance for the Full Year of 2024Herbalife Ltd. provided earnings guidance for the second quarter of 2024 and revised earnings guidance for the full year of 2024. For the quarter, the company expects net sales to be between 0% to 3% year-over-year.For the full year, the company expects net sales to be between 0% to 5% year-over-year against previous guidance of 0% to 5% year-over-year.
Reported Earnings • May 02First quarter 2024 earnings released: EPS: US$0.24 (vs US$0.30 in 1Q 2023)First quarter 2024 results: EPS: US$0.24 (down from US$0.30 in 1Q 2023). Revenue: US$1.26b (up 1.0% from 1Q 2023). Net income: US$24.3m (down 17% from 1Q 2023). Profit margin: 1.9% (down from 2.3% in 1Q 2023). Revenue is forecast to grow 3.1% p.a. on average during the next 2 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has fallen by 41% per year, which means it is performing significantly worse than earnings.
Valuation Update With 7 Day Price Move • Apr 05Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €6.96, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 19x in the Personal Products industry in Europe. Total loss to shareholders of 81% over the past three years.
お知らせ • Apr 03Herbalife Ltd. to Report Q1, 2024 Results on May 01, 2024Herbalife Ltd. announced that they will report Q1, 2024 results After-Market on May 01, 2024
Recent Insider Transactions • Mar 29Insider recently bought €140k worth of stockOn the 26th of March, Juan Mendoza bought around 16k shares on-market at roughly €8.68 per share. This transaction amounted to 58% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth €463k. Insiders have collectively bought €1.1m more in shares than they have sold in the last 12 months.
お知らせ • Mar 20+ 1 more updateHerbalife Ltd. Announces Chief Financial Officer ChangesHerbalife Ltd. announced the appointment of John DeSimone as Chief Financial Officer, succeeding Alex Amezquita who will remain with the Company. Mr. DeSimone has been an executive at Herbalife for the past 17 years, including more than 8 years as CFO from 2010 – 2018 and 4 years as President and Co-President from 2018 – 2022. Most recently, he served as a Special Advisor to the CEO.
お知らせ • Mar 07Herbalife Appoints Back Michael Levitt to Board of DirectorsHerbalife Ltd. announced the appointment of veteran finance executive, Michael Levitt, to its Board of Directors, effective March 1, 2024. Levitt previously served on the Company’s Board as the Lead Director from 2011 to 2014. Kevin Jones, who has served as a director since 2021, will step down from his role on the Board. Levitt is the Chairman of Irradiant Partners, LP, an investment management firm. He also serves as a member of the firm’s Management and Investment Committees. Prior to the launch of Irradiant Partners, he held various executive and leadership roles at several investment firms, including Kayne Anderson Capital Advisors, LP, Apollo Global Management, LLC, Smith Barney Inc. and Morgan Stanley & Co. Levitt has also served on multiple board of director positions. The Company and its Board of Directors extend sincere appreciation to Kevin Jones for his board service, valuable perspective, leadership, and commitment to Herbalife.
Recent Insider Transactions • Feb 25Chairman & CEO recently bought €463k worth of stockOn the 16th of February, Michael Johnson bought around 62k shares on-market at roughly €7.49 per share. This transaction amounted to 15% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Michael's only on-market trade for the last 12 months.
お知らせ • Feb 22Herbalife Ltd., Annual General Meeting, Apr 25, 2024Herbalife Ltd., Annual General Meeting, Apr 25, 2024, at 08:30 Pacific Standard Time.
Valuation Update With 7 Day Price Move • Feb 21Investor sentiment deteriorates as stock falls 31%After last week's 31% share price decline to €7.58, the stock trades at a forward P/E ratio of 4x. Average forward P/E is 19x in the Personal Products industry in Europe. Total loss to shareholders of 80% over the past three years.
New Risk • Feb 18New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 21% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.7x net interest cover). Negative equity (-US$1.1b). Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.8% net profit margin).
Reported Earnings • Feb 15Full year 2023 earnings released: EPS: US$1.44 (vs US$3.26 in FY 2022)Full year 2023 results: EPS: US$1.44 (down from US$3.26 in FY 2022). Revenue: US$5.06b (down 2.7% from FY 2022). Net income: US$142.2m (down 56% from FY 2022). Profit margin: 2.8% (down from 6.2% in FY 2022). Revenue is forecast to grow 2.5% p.a. on average during the next 2 years, compared to a 5.4% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has fallen by 40% per year, which means it is performing significantly worse than earnings.
お知らせ • Feb 08Herbalife Announces Launch of the Herbalife® GLP-1 Nutrition CompanionHerbalife announced the launch of the Herbalife® GLP-1 Nutrition Companion, a new range of food and supplement product combos fueled by the #1 Protein Shake in the World and intended to support the nutritional needs of individuals on GLP-1 and other weight-loss medications. Herbalife's Classic and Vegan options are now available in the United States and Puerto Rico in a variety of flavors. Recent research has shown that people taking GLP-1 weight-loss medications may experience decreases in muscle density and malnutrition. Herbalife is dedicated to addressing these nutritional deficiencies through the new combination that include nutrition products designed to deliver protein and fiber. Additionally, the Company's independent distributors create a supportive community to help consumers develop proper nutrition habits while on weight-loss drugs and maintain those habits after the drug treatment ends. The Herbalife GLP-1 Nutrition Companion includes: Classic Product Combo; Formula 1 Healthy Meal Nutritional Shake Mix (the #1 Protein Shake in the world); Protein Drink Mix; Active Fiber Complex; Vegan Product Combo; HERBALIFE V Plant-Based Digestive Support; HERBALIFE V plant-Based Digestive Support+; HERBALIFE V plants-Based Greens Booster. Each product combo provides vital protein to help build muscle tissue and maintain lean muscle mass while providing energy and fiber to promote regularity and a healthy digestive system. Additionally, the Classic combo delivers essential vitamins and minerals to support overall health, while the Vegan combo also delivers three organic blends of 20 fruits and vegetables.
お知らせ • Jan 09Herbalife Ltd. to Report Q4, 2023 Results on Feb 14, 2024Herbalife Ltd. announced that they will report Q4, 2023 results After-Market on Feb 14, 2024
Valuation Update With 7 Day Price Move • Jan 09Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €11.49, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 21x in the Personal Products industry in Europe. Total loss to shareholders of 72% over the past three years.
New Risk • Nov 02New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 3.7% Last year net profit margin: 5.7% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.5x net interest cover). Negative equity (-US$1.1b). Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Profit margins are more than 30% lower than last year (3.7% net profit margin).
Reported Earnings • Nov 02Third quarter 2023 earnings released: EPS: US$0.43 (vs US$0.84 in 3Q 2022)Third quarter 2023 results: EPS: US$0.43 (down from US$0.84 in 3Q 2022). Revenue: US$1.28b (down 1.1% from 3Q 2022). Net income: US$42.8m (down 48% from 3Q 2022). Profit margin: 3.3% (down from 6.3% in 3Q 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 31% per year, which means it is performing significantly worse than earnings.
お知らせ • Oct 21Herbalife Appoints Claire V. Groen, to Chief Human Resource OfficerHerbalife announced that Claire V. Groen has been named the new Chief Human Resource Officer, effective immediately, and is reporting to executive vice president and Chief of Staff, Ibi Montesino. In this role Ms. Groen is responsible for Herbalife's global human resource strategy and function in support of Herbalife's overall business plan. This includes providing leadership in the areas of employee engagement and culture, talent acquisition and organization design and development, diversity and inclusion, employee relations, leadership development, employee education and training, compensation and benefits and human resource information systems. Ms. Groen is a global human resources leader with over 28 years' experience in the consumer goods and professional services industries. Before joining Herbalife, she was a senior advisor with the Boston Consulting Group and prior to that role, she held numerous leadership roles at Amway for more than 15 years, including legal counsel for human resources, vice president of Global Compensation and Benefits, Global Litigation, Governance and Legal HR, and most recently as the Chief People Officer. Ms. Groen earned a Bachelor of Arts in English Literature and Philosophy from Calvin University in Grand Rapids, Michigan, and a Juris Doctorate from Indiana University's Bloomington College of Law in Bloomington, Indiana.
New Risk • Oct 13New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 8.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (8.2% average weekly change). Negative equity (-US$1.2b).
お知らせ • Oct 06Herbalife Names Susan Brown as Head of Global Corporate CommunicationsHerbalife reported that Susan Brown has been named as Head of Global Corporate Communications, and is reporting to executive vice president and Chief of Staff, Ibi Montesino. In this role, Brown is responsible for Herbalife's communications function, leading the development and execution of all internal and external communications, overseeing corporate reputation, and advancing communications strategy in support of the company's business objectives. Brown is a global corporate communications leader with more than two decades of strategic, corporate and crisis communications experience. Prior to joining Herbalife, she was the head of global corporate communications for Tyson Foods and Price Waterhouse Coopers (PWC), and held communications leadership roles at SITA, an airlines IT provider, as well as Emirates Airline & Group. She brings strong international experience having lived and worked in Germany, the Netherlands, Switzerland, the United Arab Emirates and the United States.
お知らせ • Oct 05Herbalife Ltd. to Report Q3, 2023 Results on Nov 01, 2023Herbalife Ltd. announced that they will report Q3, 2023 results After-Market on Nov 01, 2023
お知らせ • Sep 15Herbalife Ltd. Appoints Rodica Macadrai to Board of DirectorsHerbalife Ltd. announced, as part of its governance process, the Herbalife Board of Directors has appointed independent distributor, Ms. Rodica Macadrai, as a new member to the Board, effective September 10, 2023. Ms. Macadrai became an Herbalife independent distributor in 1994 in Moldova, immediately after having earned a Doctor of Medicine in Psychology from Babes Bolyai University in Cluj Napoca, Romania. Over the past 29 years she has built a global business, across 50 markets in Europe, Asia-Pacific, North America, and Latin America. In 2020, she was named to the company’s Chairman’s Club, one of the top distributor levels. Ms. Macadrai is filling the Board of Director seat made vacant when Stephan Gratziani resigned from the Board on August 1, 2023, to become the company’s Chief Strategy Officer.
Reported Earnings • Aug 03Second quarter 2023 earnings released: EPS: US$0.60 (vs US$0.88 in 2Q 2022)Second quarter 2023 results: EPS: US$0.60 (down from US$0.88 in 2Q 2022). Revenue: US$1.31b (down 5.7% from 2Q 2022). Net income: US$59.9m (down 31% from 2Q 2022). Profit margin: 4.6% (down from 6.2% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 30% per year, which means it is performing significantly worse than earnings.
お知らせ • Aug 03Herbalife Ltd. Announces Management ChangesHerbalife Ltd. announced the appointment of Stephan Paulo Gratziani to Chief Strategy Officer, effective August 4, 2023. Mr. Gratziani will report directly to Chairman and Chief Executive Officer Michael Johnson and work closely with the Company’s senior management team to implement and advance key strategic initiatives, including the Herbalife One digital technology platform and business verticals. He will also partner with senior executive and regional leadership to enhance sales training programs, promote distributor engagement, and identify growth opportunities. Mr. Gratziani brings over 32 years of experience to Herbalife as an independent distributor with a proven track record of global business growth. During his time as an independent distributor, Gratziani expanded his Herbalife business to 70 markets across North America, South America, Europe, and Asia. He was named to the Company’s Chairman’s Club in 2010, and in 2018, he achieved the highest distributor level of Founder’s Circle. Mr. Gratziani was also recognized as one of Herbalife’s top 3 independent distributors in the world for 2022. As a distributor leader, he has been an integral member of various strategy and planning groups for the Company and brings a strong analytics background and innovative entrepreneurism. Additionally, John DeSimone will transition from his position as Chief Strategic Officer to Special Advisor to the Company. On August 1, 2023, Mr. Gratziani resigned from the Company’s Board of Directors and agreed to become an employee of the Company in the role of Chief Strategy Officer. As required by the Company’s conflict of interest policy, Mr. Gratziani agreed to suspend his Herbalife distributorship and waived any rights to his distributorship earnings under the Company’s marketing plan during the term of his employment with the Company through December 31, 2025.
お知らせ • Aug 01Herbalife Introduces Herbalife V, New Product Line to Meet Increased Consumer Demand for Plant-Based OptionsHerbalife introduced Herbalife V, its latest science-based product line, to better support consumers seeking plant-based options to benefit their overall health. According to studies, plant-based lifestyles are on the rise. In fact, approximately 3% of Americans consider themselves vegan, up from 2% in 2012, while 5% are vegetarian. Additionally, almost half of Americans call themselves flexitarians. Herbalife V is backed by science and rigorously tested for quality. All products are certified USDA Organic, non-GMO-verified, Kosher, and Plant-based and Vegan by FoodChain ID. Additionally, they are formulated with no soy or dairy and made with no artificial sweeteners or flavors. The product line offers five plant-based certified products that help simplify plant-based nutrition, including: Plant-based Protein Shakes vailable in classic and chocolate flavors and formulated with 20 grams of protein (pea, pumpkin seeds, and chia).Help satisfy hunger, reduce food cravings, maintain lean muscle tone, and are an excellent source of non-heme iron. Sustain energy and promote healthy skin. Greens Booster Formulated with special blends derived from organic fruits, vegetables, superfood powders, and green tea. An easy way to add more fruits and vegetables to daily routine. Immune Support Contains vitamins C, D, and zinc to help balance and support daily immune health. Digestive Support Oat and guar fibers support a healthy gut and digestion and regularity. Herbalife V is available in the U.S. and Puerto Rico exclusively through Herbalife independent distributors. Click here to learn more about this product.
Valuation Update With 7 Day Price Move • Jul 25Investor sentiment improves as stock rises 24%After last week's 24% share price gain to €14.34, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 22x in the Personal Products industry in Europe. Total loss to shareholders of 67% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €22.41 per share.
お知らせ • Jul 06Herbalife Ltd. to Report Q2, 2023 Results on Aug 02, 2023Herbalife Ltd. announced that they will report Q2, 2023 results After-Market on Aug 02, 2023
Valuation Update With 7 Day Price Move • May 26Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to €10.59, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 21x in the Personal Products industry in Europe. Total loss to shareholders of 73% over the past three years.
Recent Insider Transactions • May 11Insider recently bought €300k worth of stockOn the 8th of May, Stephan Gratziani bought around 24k shares on-market at roughly €12.76 per share. This transaction increased Stephan Gratziani's direct individual holding by 2x at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €1.5m more in shares than they have sold in the last 12 months.
お知らせ • May 04Herbalife Ltd. Announces Executive Changes, Effective July 1, 2023Herbalife Ltd. announced senior executive leadership changes. As part of its succession management process, the Company announced Mark Schissel's retirement after 16 years of leadership contributions on July 1. Frank Lamberti will be appointed to Chief Operating Officer. In addition, the Company is announced the expanded role of Ibi Montesino, EVP and Chief of Staff, and the appointment of Rob Levy to Regional President of the Americas. All three executives will assume their roles effective July 1, 2023 and report directly to Michael Johnson, Chief Executive Officer. Schissel will assume a strategic advisory role to help ensure a smooth transition and will continue to work on special projects. In Lamberti's new role, he will oversee product innovation and supply chain, digital content and infrastructure, distributor and sales analytics, as well as back office operations. Lamberti joined Herbalife in 2005 as vice president of investor relations and has served in numerous leadership positions, including most recently, as Regional President of the Americas working closely with distributors and their customers. Prior to that, he served as executive vice president, Distributor Customer experience. He also worked internationally as senior vice president and managing director, North Asia. Montesino's expanded role will encompass all global distributor facing business including sales, marketing and distributor operation functions, as well as all aspects of employee management and relations. She joined the Company in 1998 as an assistant for personal care and then transitioned to product marketing before joining the NAM region where she served in multiple capacities including director, senior director, vice president of sales and marketing for the U.S. Latin market and eventually leading the entire North America market. Currently, as executive vice president of distributor and customer experience, she oversees functions that develop and deliver innovative tools and programs that support independent distributors and their customers. Rob Levy has been appointed Regional President of the Americas and will be responsible for all strategic, sales and marketing functions across the region. As head of the Americas, his oversight includes North America, South and Central America, Mexico and Brazil. Levy, a longtime Herbalife industry veteran with 28 years at the Company, has run every region during his tenure, and was key to the Company's expansion to half the markets the Company has today. He is currently serving as EVP Worldwide Distributor Affairs.
Reported Earnings • May 03First quarter 2023 earnings released: EPS: US$0.30 (vs US$0.98 in 1Q 2022)First quarter 2023 results: EPS: US$0.30 (down from US$0.98 in 1Q 2022). Revenue: US$1.25b (down 6.3% from 1Q 2022). Net income: US$29.3m (down 70% from 1Q 2022). Profit margin: 2.3% (down from 7.4% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings.
Recent Insider Transactions • Feb 27Independent Director recently bought €273k worth of stockOn the 22nd of February, Donal Mulligan bought around 15k shares on-market at roughly €18.17 per share. This transaction amounted to 83% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €2.6m more in shares than they have sold in the last 12 months.
Valuation Update With 7 Day Price Move • Feb 21Investor sentiment improves as stock rises 23%After last week's 23% share price gain to €18.90, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 24x in the Personal Products industry in Europe. Total loss to shareholders of 44% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €10.81 per share.
Reported Earnings • Feb 15Full year 2022 earnings released: EPS: US$3.26 (vs US$4.22 in FY 2021)Full year 2022 results: EPS: US$3.26 (down from US$4.22 in FY 2021). Revenue: US$5.20b (down 10% from FY 2021). Net income: US$321.3m (down 28% from FY 2021). Profit margin: 6.2% (down from 7.7% in FY 2021). The decrease in margin was driven by lower revenue. Revenue is expected to decline by 1.2% p.a. on average during the next 2 years, while revenues in the Personal Products industry in Europe are expected to grow by 5.0%. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.
お知らせ • Jan 18Herbalife Nutrition Ltd. to Report Q4, 2022 Results on Feb 14, 2023Herbalife Nutrition Ltd. announced that they will report Q4, 2022 results at 4:00 PM, US Eastern Standard Time on Feb 14, 2023
お知らせ • Nov 01+ 2 more updatesHerbalife Nutrition Ltd. Withdraws Earnings Guidance for the Year 2022Herbalife Nutrition Ltd. Withdraws earnings guidance for the year 2022. Given the rapidly shifting macroeconomic sentiment and backdrop, as well as increased volatility in the marketplace, the Company is withdrawing Fiscal Year 2022 guidance. The Company will periodically reassess its ability to provide guidance when it believe future performance can be reasonably estimated.
お知らせ • Oct 04Herbalife Nutrition Ltd. to Report Q3, 2022 Results on Oct 31, 2022Herbalife Nutrition Ltd. announced that they will report Q3, 2022 results at 4:00 PM, US Eastern Standard Time on Oct 31, 2022
Reported Earnings • Aug 03Second quarter 2022 earnings released: EPS: US$0.88 (vs US$1.34 in 2Q 2021)Second quarter 2022 results: EPS: US$0.88 (down from US$1.34 in 2Q 2021). Revenue: US$1.39b (down 10% from 2Q 2021). Net income: US$86.5m (down 40% from 2Q 2021). Profit margin: 6.2% (down from 9.3% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is expected to shrink by 1.7% compared to a 7.7% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
お知らせ • Aug 03Herbalife Nutrition Ltd. Provides Revenue Guidance for the Three Months Ending September 30, 2022 and Twelve Months Ending December 31, 2022Herbalife Nutrition Ltd. provided revenue guidance for the three months ending September 30, 2022 and twelve months ending December 31, 2022. For the three months ending September 30, 2022, negative net sales growth (Decline) is in the range of 9% to 3%. For the twelve months ending December 31, 2022, negative net sales growth (Decline) is in the range of 10% to 4%.
Valuation Update With 7 Day Price Move • Jul 19Investor sentiment improved over the past weekAfter last week's 16% share price gain to €22.45, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 26x in the Personal Products industry in Europe. Total loss to shareholders of 39% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €26.61 per share.
お知らせ • Jul 17Herbalife Nutrition Introduces a New Product to Help Consumers Get Back on Track with Their Healthy LifestyleHerbalife Nutrition introduced its latest science-backed product, Fat Release, to support its consumers' healthy and active lifestyles. According to a recent U.S.study by OnePoll, the average person overindulges in unhealthy food three nights per week, and when a person is working to maintain a healthy lifestyle or on a weight loss journey, overindulging affects their health goals. This product helps trim the fat from food to keep consumers on track with their health goals. While this new product is not a stand-alone weight loss product, it can be helpful to consumers who indulge and have fatty foods as part of a meal, if consumed within two hours of the meal. Fat Release is formulated with Litramine®, the beneficial ingredient in the product, which is derived from prickly pear and is a patented cactus fiber ingredient that helps trim the fat from food. The Fruit Twist flavor powdered stick pack contains 30 single servings and can be consumed straight from the pack, no water required or added to 8 fl. oz. of hot or cold water.
お知らせ • Jul 06Herbalife Nutrition Ltd. to Report Q2, 2022 Results on Aug 02, 2022Herbalife Nutrition Ltd. announced that they will report Q2, 2022 results at 4:00 PM, US Eastern Standard Time on Aug 02, 2022
お知らせ • May 04Herbalife Nutrition Ltd. Provides Earnings Guidance for the Three Months Ending June 30, 2022 and Twelve Months Ending December 31, 2022Herbalife Nutrition Ltd. provided earnings guidance for the three months ending June 30, 2022 and twelve months ending December 31, 2022. For the three months, the company expects negative net sales growth vs 2021 in the range of 17.5% and 11.5%.For the twelve months, the company expects negative net sales growth vs 2021 in the range of 10% and 4%.
お知らせ • Apr 06Herbalife Nutrition Ltd. to Report Q1, 2022 Results on May 03, 2022Herbalife Nutrition Ltd. announced that they will report Q1, 2022 results After-Market on May 03, 2022
お知らせ • Feb 25Herbalife Nutrition Ltd., Annual General Meeting, Apr 27, 2022Herbalife Nutrition Ltd., Annual General Meeting, Apr 27, 2022.
お知らせ • Feb 24Herbalife Nutrition Ltd. Provides Earnings Guidance for the First Quarter Ending March 31, 2022 and Full Year Ending December 31, 2022Herbalife Nutrition Ltd. provided earnings guidance for the first quarter ending March 31, 2022 and full year ending December 31, 2022. For the quarter, the company expects negative net sales guidance range of 10% - 4% growth.For the year, the company initiating Fiscal Year 2022 net sales guidance range of 0% - 6% growth.
Reported Earnings • Feb 24Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: US$4.22 (up from US$2.83 in FY 2020). Revenue: US$5.80b (up 4.7% from FY 2020). Net income: US$447.2m (up 20% from FY 2020). Profit margin: 7.7% (up from 6.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to stay flat compared to a 8.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 03Third quarter 2021 earnings released: EPS US$1.11 (vs US$1.07 in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: US$1.43b (down 6.0% from 3Q 2020). Net income: US$117.4m (down 15% from 3Q 2020). Profit margin: 8.2% (down from 9.1% in 3Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
Recent Insider Transactions • Sep 22Chairman & CEO recently bought €191k worth of stockOn the 17th of September, John Agwunobi bought around 5k shares on-market at roughly €38.25 per share. In the last 3 months, they made an even bigger purchase worth €212k. John has been a buyer over the last 12 months, purchasing a net total of €403k worth in shares.
Valuation Update With 7 Day Price Move • Sep 16Investor sentiment deteriorated over the past weekAfter last week's 21% share price decline to €36.06, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 33x in the Personal Products industry in Europe. Total loss to shareholders of 22% over the past three years.
お知らせ • Sep 15Herbalife Nutrition Lowers Third Quarter and Full Year 2021 GuidanceHerbalife Nutrition Ltd. announced that it is revising its third quarter and full year 2021 guidance. Recently, the Company observed lower than expected levels of activity amongst its independent distributors that has led to a decrease in expected third quarter and full year net sales. Despite this, the company anticipates net sales growth in the third quarter to be between approximately 14% to 18% versus third quarter 2019 and growth for the full year to be between approximately 19% to 23% versus full year 2019.
